LOVENOX 30 000 IU (300 mg)/3 ml, solution for injection bottle, 3 ml
Brand page: Lovenox (enoxaparin sodium) — all forms and strengths in France
Active ingredients: ÉNOXAPARINE SODIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 3 mlintraveineuse;sous-cutanée;voie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOVENOX 30 000 UI (300 mg)/3 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée;voie extracorporelle autre
- Presentation description
- 1 flacon(s) multidose en verre de 3 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jul 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67753717CIP75610708CIP133400956107087Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉNOXAPARINE SODIQUEsolution | 300 mg · 3 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.